Emerging Nano medicine

Currently,the treatment of HIV requires regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies.Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown.Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle(SDN)technology which can improve drug absorption into the body,reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.

 

  • raphene Medicine
  • Image-guided drug delivery
  • Nanomedicine for Diabetes
  • Nanomedicine for Cancer
  • NanoMedicine for HIV

Related Conference of Emerging Nano medicine

April 11-12, 2024

41th Global Nanotechnology Congress

Amsterdam, Netherlands
April 25-26, 2024

36th Nano Congress for Future Advancements

London, UK
May 16-17, 2024

27th World Nanotechnology Congress

Rome, Italy

Emerging Nano medicine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in